The evolution of the axillofemoral bypass over two decades

Niren Angle, Amir Dorafshar, Michael M. Farooq, Samuel S. Ahn, Hugh A. Gelabert, William J. Quiñones-Baldrich, Wesley S. Moore, Julie A. Freischlag

Research output: Contribution to journalArticle

Abstract

To determine if the indications and numbers of the axillofemoral bypass have changed, a retrospective analysis was performed of all patients undergoing axillofemoral bypass over the past two decades. Group A (1980-89) and group B (1990-99) were compared using demographics, comorbid illness, perioperative outcomes, and indications for operation. There were 33 extraanatomic bypasses performed in group A and 24 extraanatomic bypasses in group B. The average age in both group A and group B was 69 years. Males comprised a higher percentage in group B (75%) than in group A (55%). The percentage of smokers was roughly equivalent (group A 76%, group B 71%). Coronary artery disease was more prevalent in group A (85%) than in group B (63%). Diabetes mellitus was also more common in group A (33%) than in group B (21%). All of the grafts in group B were composed of PTFE and there were 2 early (30 day) failures (6%). There were no perioperative deaths, strokes, or myocardial infarctions. At our institution, the axillofemoral bypass is now reserved almost exclusively for the treatment of graft infections and rarely for primary limb ischemia. This evolution is a reflection of the increase in interventional techniques used to improve inflow in high-risk patients who require revascularization.

Original languageEnglish (US)
Pages (from-to)742-745
Number of pages4
JournalAnnals of Vascular Surgery
Volume16
Issue number6
DOIs
StatePublished - Nov 2002
Externally publishedYes

Fingerprint

Transplants
Polytetrafluoroethylene
Coronary Artery Disease
Diabetes Mellitus
Ischemia
Extremities
Stroke
Myocardial Infarction
Demography
Infection
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Angle, N., Dorafshar, A., Farooq, M. M., Ahn, S. S., Gelabert, H. A., Quiñones-Baldrich, W. J., ... Freischlag, J. A. (2002). The evolution of the axillofemoral bypass over two decades. Annals of Vascular Surgery, 16(6), 742-745. https://doi.org/10.1007/s10016-001-0182-9

The evolution of the axillofemoral bypass over two decades. / Angle, Niren; Dorafshar, Amir; Farooq, Michael M.; Ahn, Samuel S.; Gelabert, Hugh A.; Quiñones-Baldrich, William J.; Moore, Wesley S.; Freischlag, Julie A.

In: Annals of Vascular Surgery, Vol. 16, No. 6, 11.2002, p. 742-745.

Research output: Contribution to journalArticle

Angle, N, Dorafshar, A, Farooq, MM, Ahn, SS, Gelabert, HA, Quiñones-Baldrich, WJ, Moore, WS & Freischlag, JA 2002, 'The evolution of the axillofemoral bypass over two decades', Annals of Vascular Surgery, vol. 16, no. 6, pp. 742-745. https://doi.org/10.1007/s10016-001-0182-9
Angle N, Dorafshar A, Farooq MM, Ahn SS, Gelabert HA, Quiñones-Baldrich WJ et al. The evolution of the axillofemoral bypass over two decades. Annals of Vascular Surgery. 2002 Nov;16(6):742-745. https://doi.org/10.1007/s10016-001-0182-9
Angle, Niren ; Dorafshar, Amir ; Farooq, Michael M. ; Ahn, Samuel S. ; Gelabert, Hugh A. ; Quiñones-Baldrich, William J. ; Moore, Wesley S. ; Freischlag, Julie A. / The evolution of the axillofemoral bypass over two decades. In: Annals of Vascular Surgery. 2002 ; Vol. 16, No. 6. pp. 742-745.
@article{99c1495ad1374eb3ad90d501cead235a,
title = "The evolution of the axillofemoral bypass over two decades",
abstract = "To determine if the indications and numbers of the axillofemoral bypass have changed, a retrospective analysis was performed of all patients undergoing axillofemoral bypass over the past two decades. Group A (1980-89) and group B (1990-99) were compared using demographics, comorbid illness, perioperative outcomes, and indications for operation. There were 33 extraanatomic bypasses performed in group A and 24 extraanatomic bypasses in group B. The average age in both group A and group B was 69 years. Males comprised a higher percentage in group B (75{\%}) than in group A (55{\%}). The percentage of smokers was roughly equivalent (group A 76{\%}, group B 71{\%}). Coronary artery disease was more prevalent in group A (85{\%}) than in group B (63{\%}). Diabetes mellitus was also more common in group A (33{\%}) than in group B (21{\%}). All of the grafts in group B were composed of PTFE and there were 2 early (30 day) failures (6{\%}). There were no perioperative deaths, strokes, or myocardial infarctions. At our institution, the axillofemoral bypass is now reserved almost exclusively for the treatment of graft infections and rarely for primary limb ischemia. This evolution is a reflection of the increase in interventional techniques used to improve inflow in high-risk patients who require revascularization.",
author = "Niren Angle and Amir Dorafshar and Farooq, {Michael M.} and Ahn, {Samuel S.} and Gelabert, {Hugh A.} and Qui{\~n}ones-Baldrich, {William J.} and Moore, {Wesley S.} and Freischlag, {Julie A.}",
year = "2002",
month = "11",
doi = "10.1007/s10016-001-0182-9",
language = "English (US)",
volume = "16",
pages = "742--745",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - The evolution of the axillofemoral bypass over two decades

AU - Angle, Niren

AU - Dorafshar, Amir

AU - Farooq, Michael M.

AU - Ahn, Samuel S.

AU - Gelabert, Hugh A.

AU - Quiñones-Baldrich, William J.

AU - Moore, Wesley S.

AU - Freischlag, Julie A.

PY - 2002/11

Y1 - 2002/11

N2 - To determine if the indications and numbers of the axillofemoral bypass have changed, a retrospective analysis was performed of all patients undergoing axillofemoral bypass over the past two decades. Group A (1980-89) and group B (1990-99) were compared using demographics, comorbid illness, perioperative outcomes, and indications for operation. There were 33 extraanatomic bypasses performed in group A and 24 extraanatomic bypasses in group B. The average age in both group A and group B was 69 years. Males comprised a higher percentage in group B (75%) than in group A (55%). The percentage of smokers was roughly equivalent (group A 76%, group B 71%). Coronary artery disease was more prevalent in group A (85%) than in group B (63%). Diabetes mellitus was also more common in group A (33%) than in group B (21%). All of the grafts in group B were composed of PTFE and there were 2 early (30 day) failures (6%). There were no perioperative deaths, strokes, or myocardial infarctions. At our institution, the axillofemoral bypass is now reserved almost exclusively for the treatment of graft infections and rarely for primary limb ischemia. This evolution is a reflection of the increase in interventional techniques used to improve inflow in high-risk patients who require revascularization.

AB - To determine if the indications and numbers of the axillofemoral bypass have changed, a retrospective analysis was performed of all patients undergoing axillofemoral bypass over the past two decades. Group A (1980-89) and group B (1990-99) were compared using demographics, comorbid illness, perioperative outcomes, and indications for operation. There were 33 extraanatomic bypasses performed in group A and 24 extraanatomic bypasses in group B. The average age in both group A and group B was 69 years. Males comprised a higher percentage in group B (75%) than in group A (55%). The percentage of smokers was roughly equivalent (group A 76%, group B 71%). Coronary artery disease was more prevalent in group A (85%) than in group B (63%). Diabetes mellitus was also more common in group A (33%) than in group B (21%). All of the grafts in group B were composed of PTFE and there were 2 early (30 day) failures (6%). There were no perioperative deaths, strokes, or myocardial infarctions. At our institution, the axillofemoral bypass is now reserved almost exclusively for the treatment of graft infections and rarely for primary limb ischemia. This evolution is a reflection of the increase in interventional techniques used to improve inflow in high-risk patients who require revascularization.

UR - http://www.scopus.com/inward/record.url?scp=0036877448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036877448&partnerID=8YFLogxK

U2 - 10.1007/s10016-001-0182-9

DO - 10.1007/s10016-001-0182-9

M3 - Article

C2 - 12424558

AN - SCOPUS:0036877448

VL - 16

SP - 742

EP - 745

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

IS - 6

ER -